An Illustrated Look at Cronos Group Following their Q3 Earnings

As a follow up to our quick take this morning on Cronos Group (TSX: CRON, NASDAQ: CRON), we thought it would be helpful to share an illustrated look at Cronos Q3 earnings.

Cronos effectively doubled their cannabis output since Q2, selling 3,100 kg of dried gram cannabis equivalents. That’s about half of Aphria’s most recent quarterly unit sales and a sixth of Aurora’s.

Inventory is climbing steadily. The low BA total may represent the quarter’s end catching the grow rooms between cycles.
Cronos still lags other mid tier cultivators in unit sales…
…but they’re catching up

Yet, Cronos’ enterprise value is nearly identical to Aphria’s, and less than a third of Aurora’s. Whether this apparent value gap is tradeable is a matter of opinion, but few would argue with the notion that its roots are in Cronos’ financial position, relative to its peers, and in its backers.

Cronos has $1.92 billion in cash. That’s more than half of its market cap. The company carries no debt. The cash originated in the $2.4 billion equity investment made by US tobacco giant Altria this past December. Altria plans to use Cronos as its cannabis platform globally.

The tobacco business isn’t going anywhere and, more to the point, they have the background and understanding to make this particular type of consumer goods business work.

Cronos does not appear to be bothered by the fact that, among the unicorn-class Canadian cultivators, they have the smallest unit sales. Part of that is the strong growth, but it’s entirely possible that their US backers don’t expect this business to succeed as a Canadian cultivator. Altria may be content to use Canada as a sort of R&D lab. The retail footprint from their tobacco division can be considered a far better head start in the US market than all of the MSO front runners put together. From Altria’s perspective, the key to success in a US cannabis landscape that allows them to participate may well be the consumer product knowledge that they gain from their Cronos experiment.


Information for this analysis was found via Sedar and Cronos Group. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Heritage Cannabis Director Resigns Just Ahead Of Year End

When we last checked in with our favorite Canadian extraction play Heritage Cannabis (CSE:CANN) in...

Tuesday, February 11, 2020, 08:45:11 AM

Cronos Group Licenses IP From Aurora Cannabis, 22nd Century Group Related To Biosynthesis

Aurora Cannabis (TSX:ACB) has reportedly entered into a licensing arrangement with 22nd Century Group (NASDAQ:...

Wednesday, December 15, 2021, 09:21:00 AM

Cronos Group Finally Files Q3 Results, Announces Business Realignment

It may be more than three months later than initially expected, but Cronos Group (TSX:...

Friday, February 18, 2022, 08:09:49 AM

Are Big Liquor And Tobacco Bankrolling Cannabis, Or Killing It?

Markets have been unkind to cannabis investors, and made certain fundamentals-based business bloggers, who were...

Saturday, June 6, 2020, 12:13:26 PM

Cronos Group Sees Adler, Gorenstein Sell Multiple Millions Worth Of Shares

November has been a busy month for Cronos Group (TSX: CRON) (NASDAQ: CRON) in terms...

Thursday, November 19, 2020, 05:36:05 PM